Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type I Diabetes I: Introduction

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Antigens Involved in Adaptive Immunity

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Seco-Duocarmycin SA Augments the Impact of Proton Radiation on Human Glioblastoma Cells.

International journal of molecular sciences·2026

Same author

Toll-like Receptor 4 Contributes to PCOS-like Metabolic and Reproductive Pathogenesis.

bioRxiv : the preprint server for biology·2025

Same author

Women in STEM becoming independent: Asking for help creates opportunities for connections and kindness.

The Journal of experimental medicine·2025

Same author

Nicotinic acid riboside maintains NAD<sup>+</sup> homeostasis and ameliorates aging-associated NAD<sup>+</sup> decline.

Cell metabolism·2025

Same author

Nicotinic acid riboside maintains NAD<sup>+</sup> homeostasis and ameliorates aging-associated NAD<sup>+</sup> decline.

Cell metabolism·2025

Same author

Time for lipid cell biology.

Nature cell biology·2025

Search research articles

Related Experiment Video

Updated: Jun 2, 2026

Extraction of Tissue Antigens for Functional Assays

Extraction of Tissue Antigens for Functional Assays

Published on: September 10, 2012

Autoantigen based vaccines for type 1 diabetes.

Dequina Nicholas¹, Oludare Odumosu, William H R Langridge

¹Center for Health Disparities and Molecular Medicine, Department of Biochemistry, Loma Linda University School of Medicine, California 92354, USA.

Discovery Medicine

|April 29, 2011

Summary

Multi-component vaccines combining autoantigens with immune-modulating molecules show promise for preventing and reversing type 1 diabetes autoimmunity in preclinical models, suggesting potential for human clinical studies.

More Related Videos

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

Electrochemiluminescence Assays for Human Islet Autoantibodies

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

Related Experiment Videos

Last Updated: Jun 2, 2026

Extraction of Tissue Antigens for Functional Assays

Extraction of Tissue Antigens for Functional Assays

Published on: September 10, 2012

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

Electrochemiluminescence Assays for Human Islet Autoantibodies

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

Area of Science:

Immunology
Endocrinology
Vaccinology

Background:

Type 1 diabetes is an autoimmune disease targeting pancreatic beta cells, initiated by immune cells like dendritic cells processing beta-cell autoantigens.
Current treatments do not offer a cure, but strategies like autoantigen inoculation in the non-obese diabetic (NOD) mouse model show potential for mitigating insulitis.

Purpose of the Study:

To explore the development of autoantigen vaccines for type 1 diabetes.
To evaluate the efficacy of multi-component vaccines in preventing and reversing diabetes autoimmunity.

Main Methods:

Review of autoantigen vaccines including single peptides (insulin, GAD65, DiaPep277) and combination strategies.
Focus on multi-component vaccines incorporating anti-inflammatory cytokines (IL-10) and immunostimulatory molecules (cholera toxin B subunit) with autoantigens.

Main Results:

Single autoantigen vaccines like DiaPep277 have shown promise in human trials, while GAD65 formulations (Diamyd) preserved insulin secretion but did not eliminate the need for insulin therapy.
Multi-component vaccines safely and completely inhibited diabetes onset in NOD mice, demonstrating significant therapeutic potential.

Conclusions:

Multi-component vaccine strategies represent a promising avenue for the prevention and reversal of type 1 diabetes autoimmunity.
These findings support the advancement of multi-component vaccines into human clinical studies for type 1 diabetes treatment.